Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s stock price passed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $2.00 and traded as low as $1.65. Ampliphi Biosciences shares last traded at $1.65, with a volume of 6,450 shares trading hands.
Ampliphi Biosciences Trading Down 4.2 %
The firm’s 50-day moving average price is $2.00.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
Featured Stories
- Five stocks we like better than Ampliphi Biosciences
- How to Plot Fibonacci Price Inflection Levels
- Venezuelan Tariffs Could Power These 3 Diesel-Driven Winners
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- MarketBeat Week in Review – 03/24 – 03/28
- The How And Why of Investing in Oil Stocks
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
